Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Logan A Walsh

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Journal of Cell Communication and Signaling|January 10, 2012
Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cellsLogan A Walsh, Mario A Cepeda, Sashko Damjanovski
The International Journal of Developmental Biology|July 10, 2007
Soluble membrane-type 3 matrix metalloprioteinase causes changes in gene expression and increased gelatinase activity during Xenopus laevis developmentLogan A Walsh, Colin A Cooper, Sashko Damjanovski
Protein & Cell|March 14, 2014
Driver mutations of cancer epigenomesDavid M Roy, Logan A Walsh, Timothy A Chan
BMC Developmental Biology|April 30, 2011
PEX11β induces peroxisomal gene expression and alters peroxisome number during early Xenopus laevis developmentMark A Fox, Logan A Walsh, Michelle Nieuwesteeg, et al.
Plos One|October 4, 2007
Membrane type-1 matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 RNA levels mimic each other during Xenopus laevis metamorphosisLogan A Walsh, Deanna A Carere, Colin A Cooper, et al.
Nature Genetics|December 8, 2023
CellCharter reveals spatial cell niches associated with tissue remodeling and cell plasticityMarco Varrone, Daniele Tavernari, Albert Santamaria-Martínez, et al.
The Journal of Pathology|January 26, 2019
The innate immune architecture of lung tumors and its implication in disease progressionSimon Milette, Pierre O Fiset, Logan A Walsh, et al.
The Lancet. Oncology|August 2, 2021
Pathological complete response as a surrogate endpoint after neoadjuvant therapy for lung cancerCaroline Huynh, Mark Sorin, Roni Rayes, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2023
Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat GlioblastomaAnudeep Surendran, Adrianne L Jenner, Elham Karimi, et al.
The Journal of Investigative Dermatology|September 23, 2011
Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangiomaShoshana Greenberger, Siming Yuan, Logan A Walsh, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Journal of Cell Communication and Signaling|January 10, 2012
Analysis of the MMP-dependent and independent functions of tissue inhibitor of metalloproteinase-2 on the invasiveness of breast cancer cellsLogan A Walsh, Mario A Cepeda, Sashko Damjanovski
The International Journal of Developmental Biology|July 10, 2007
Soluble membrane-type 3 matrix metalloprioteinase causes changes in gene expression and increased gelatinase activity during Xenopus laevis developmentLogan A Walsh, Colin A Cooper, Sashko Damjanovski
Protein & Cell|March 14, 2014
Driver mutations of cancer epigenomesDavid M Roy, Logan A Walsh, Timothy A Chan
BMC Developmental Biology|April 30, 2011
PEX11β induces peroxisomal gene expression and alters peroxisome number during early Xenopus laevis developmentMark A Fox, Logan A Walsh, Michelle Nieuwesteeg, et al.
Plos One|October 4, 2007
Membrane type-1 matrix metalloproteinases and tissue inhibitor of metalloproteinases-2 RNA levels mimic each other during Xenopus laevis metamorphosisLogan A Walsh, Deanna A Carere, Colin A Cooper, et al.
Nature Genetics|December 8, 2023
CellCharter reveals spatial cell niches associated with tissue remodeling and cell plasticityMarco Varrone, Daniele Tavernari, Albert Santamaria-Martínez, et al.
The Journal of Pathology|January 26, 2019
The innate immune architecture of lung tumors and its implication in disease progressionSimon Milette, Pierre O Fiset, Logan A Walsh, et al.
The Lancet. Oncology|August 2, 2021
Pathological complete response as a surrogate endpoint after neoadjuvant therapy for lung cancerCaroline Huynh, Mark Sorin, Roni Rayes, et al.
The Journal of Pharmacology and Experimental Therapeutics|July 13, 2023
Agent-Based Modelling Reveals the Role of the Tumor Microenvironment on the Short-Term Success of Combination Temozolomide/Immune Checkpoint Blockade to Treat GlioblastomaAnudeep Surendran, Adrianne L Jenner, Elham Karimi, et al.
The Journal of Investigative Dermatology|September 23, 2011
Rapamycin suppresses self-renewal and vasculogenic potential of stem cells isolated from infantile hemangiomaShoshana Greenberger, Siming Yuan, Logan A Walsh, et al.
Pageof 6